abstract |
The present invention relates to a novel compound which inhibits the activity of Lp-PLA2, a process for the preparation thereof, a composition containing the same, and a disease thereof for treating Lp-PLA2 activity (for example, atherosclerosis, Alzheimer's disease and / or use of diabetic macular edema. |